105 related articles for article (PubMed ID: 38733152)
1. Hyaluronic acid-coated liposomes for enhanced
Lv H; Miao M; Wu Z; Huang C; Tang X; Yan R
J Liposome Res; 2024 May; ():1-12. PubMed ID: 38733152
[TBL] [Abstract][Full Text] [Related]
2. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
4. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation.
Tang X; Sun J; Ge T; Zhang K; Gui Q; Zhang S; Chen W
Colloids Surf B Biointerfaces; 2018 Dec; 172():26-36. PubMed ID: 30125771
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamic evaluation of hyaluronic acid-modified imatinib-loaded PEGylated liposomes in CD44-positive Gist882 tumor-bearing mice.
Huang J; Chen J
J Liposome Res; 2024 Mar; 34(1):97-112. PubMed ID: 37401372
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of neogambogic acid-induced apoptosis in human MCF-7 cells.
Wang K; Tang Y; Sun M; Lu B; Zhu H; Ji O; Shen Q
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):698-702. PubMed ID: 21785112
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy.
Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H
Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
[TBL] [Abstract][Full Text] [Related]
10. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
[TBL] [Abstract][Full Text] [Related]
11. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
[TBL] [Abstract][Full Text] [Related]
12. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
[TBL] [Abstract][Full Text] [Related]
13. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
[No Abstract] [Full Text] [Related]
14. Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684
[TBL] [Abstract][Full Text] [Related]
15. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
16. HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma.
Zhang X; Chen H; Zhang Y; Huang Q; Feng J; Xing H; Fu X; Yan X; Zhang Y; Xu Q; Liang J
Int J Nanomedicine; 2022; 17():5137-5151. PubMed ID: 36345507
[TBL] [Abstract][Full Text] [Related]
17. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
19. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
[TBL] [Abstract][Full Text] [Related]
20. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]